Références

1. Chatterjee A, Pakrashi SC. The Treatise on Indian Medicinal Plants 1995;4:208-212.
2. Bone K. Clinical Applications of Ayurvedic and Chinese Herbs. Monographs for the Western Herbal Practitioner. Australia: Phytotherapy Press; 1996:137-141.
3. Anbalagan K, Sadique J. Influence of an Indian medicine (Ashwagandha) on acutephase reactants in inflammation. Indian J Ex  Biol 1981;19:245-249.
4. Anbalagan K, Sadique J. Role of prostaglandins in acute phase proteins in inflammation. Biochem Med 1984;31:236-245.
5. Somasundaram S, Sadique J, Subramoniam A.Influence of extra-intestinal inflammation on the in vitro absorption of 14C-glucose and the effects of anti-inflammatory drugs in the jejunum of rats. Clin Exp Pharmacol Physiol 1983;10:147-152.
6. Somasundaram S, Sadique J, Subramoniam A. In vitro absorption of [14C]leucine during inflammation and the effect of antiinflammatory drugs in the jejunum of rats. Biochem Med 1983;29:259-264.
7. Dadkar VN, Ranadive NU, Dhar HL. Evaluation of antistress (adaptogen) activity of Withania somnifera (Ashwagandha). Ind J Clin Biochem 1987,2:101-108.
8. Archana R, Namasivayan A. Antistressor effect of Withania somnifera. J Ethnopharmacol 1999;64:91-93.
9. Dhuley JN. Effect of ashwagandha on lipid peroxidation in stress-induced animals. J Ethnopharmacol 1998;60:173-178.
10. Singh N, Nath R, Lata A, et al. Withania somnifera (ashwagandha), a rejuvenating herbal drug which enhances survival during
stress (an adaptogen). Int J Crude Drug Res 1982;20:29-35.
11. Singh N, Singh SP, Nath R, et al. Prevention of urethane-induced lung adenomas by Withania somnifera (L.) Dunal in albino mice. Int J Crude Drug Res 1986;24:90-100.
12. Devi PU, Sharada AC, Solomon FE, Kamath MS. In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma 180. Indian J Exp Biol 1992;30:169-172.
13. Devi PU. Withania somnifera dunal (ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Indian J Exp Biol 1996;34:927-932.
14. Devi PU, Sharada AC, Solomon FE. In vivo growth inhibitory and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma. Cancer Lett 1995;95:189-193.
15. Sharad AC, Solomon FE, Devi PU, et al. Antitumor and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma in vivo. Acta Oncol 1996;35:95-100.
16. Lazarev NV. Farmacol Toxicol 1958;21:81-86. As cited in Brekhman II, Dardymov IV. New substances of plant origin which increase non-specific resistance. Annu Rev Pharmacol 1969;9:419-430.
17. Brekhman II. Panax Ginseng. Med Sci Serv 1967;4:17-26.
18. Brekhman II, Dardymov IV. New substances of plant origin which increase non-specific resistance. Annu Rev Pharmacol 1969;9:419-430.
19. Rastogi RP, Mehrotra BN. Compendium of Indian Medicinal Plants, Vol.6. Central Drug Research Institute, New Delhi, 1998.
20. Begum VH, Sadique J. Effect of Withania somnifera on glycosaminoglycan synthesis in carrageenin-induced air pouch granuloma.
Biochem Med Metab Biol 1987;38:272-277.
21. Begum VH, Sadique J. Long term effect of herbal drug Withania somnifera on adjuvant induced arthritis in rats. Indian J Exp Biol 1988;26:877-882.
22. al Hindawi MK, al Khafaji SH, Abdul-Nabi MH. Anti-granuloma activity of Iraqi Withania somnifera. J Ethnopharmacol 1992;37:113-116.
23. Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 1991;33:91-95.
24. Bhattacharya SK, Goel RK, Kaur R, Ghosal S. Antistress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withania
somnifera. Phytotherapy Res 1987;1:32-39.
25. Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and Ginseng. J Ethnopharmacol 1994;44:131-135.
26. Halliwell B, Gutteridge JMC. Free Radicals in Biology & Medicine. 2nd ed. Oxford: Clarendon Press; 1989.
27. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993;90:7915-7922.
28. Jesberger JA, Richardson JS. Oxygen free radicals and brain dysfunction. Int J Neurosci 1991;57:1-17.
29. Scarfiotti C, Fabris F, Cestaro B, Giuliani A. Free radicals, atherosclerosis, ageing, and related dysmetabolic pathologies: pathological and clinical aspects. Eur J Cancer Prev 1997;6:S31-S36.
30. Bhattacharya SK, Satyan KS, Chakrabarti A. Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J Exp Biol 1997;35:297-299.
31. Ghosal S, Lal J, Srivastava R, et al. Immunomodulatory and CNS effects of sitoindosides IX and X, two new glycowithanolides from Withania somnifera. Phytotherapy Res 1989;3:201-206.
32. Ziauddin M, Phansalkar N, Patki P, et al. Studies on the immunomodulatory effects of ashwagandha. J Ethnopharmacol 1996 Feb;50:69-76.
33. Dhuley JN. Effect of some Indian herbs on macrophage functions in ochratoxin A treated mice. J Ethnopharmacol 1997;58:15-20.
35. Venkataraghavan S, Seshadri C, Sundaresan TP, et al. The comparative effect of milk fortified with aswagandha, aswagandha and punarnava in children – a double-blind study. J Res Ayur Sid 1980;1:370-385.
36. Kuppurajan K, et al. J Res Ayu Sid 1, 247, 1980. As cited in Bone K. Clinical Applications of Ayurvedic and Chinese Herbs. Monographs for the Western Herbal Practitioner. Australia: Phytotherapy Press; 1996:137-141.
37. Malhotra CL, Mehta VL, Das PK, Dhalla NS. Studies on Withania-ashwagandha, Kaul. V. The effect of total alkaloids (ashwagandholine) on the central nervous system. Indian J Physiol Pharmacol 1965;9:127-136.
38. Schliebs R, Liebmann A, Bhattacharya SK, et al. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and
Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int 1997;30:181-190.
39. Malhotra CL, Mehta VL, Prasad K, Das PK. Studies on Withania ashwagandha, Kaul. IV. The effect of total alkaloids on the smooth muscles. Indian J Physiol Pharmacol 1965;9:9-15.
40. Panda S, Kar A. Evidence for free radical scavenging activity of ashwagandha root powder in mice. Indian J Physiol Pharmacol 1997;41:424-426.
41. Panda S, Kar A. Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male mice. J Pharm Pharmacol 1998;50:1065-1068.
42. Malhotra CL, Das PK, Dhalla NS, Prasad K. Studies on Withania ashwagandha, Kaul. III. The effect of total alkaloids on the cardiovascular system and respiration. Indian J Med Res 1981;49:448-460.
43. Arseculeratne SN, Gunatilaka AA, Panabokke RG. Studies of medicinal plants of Sri Lanka. Part 14: Toxicity of some traditional medicinal herbs. J Ethnopharmacol 1985;13:323-335.
44. Sharma S, Dahanukar S, Karandikar SM. Effects of long-term administration of the roots of ashwagandha (Withania somnifera) and shatavari (Asparagus racemosus) in rats. Indian Drugs 1986;23:133-139.